Home Disarm Therapeutics

Disarm Therapeutics

In operation
Series A
New Drug Development Company
Basic
Enterprise Profile

Basic Information

Disarm Therapeutics is dedicated to developing SARM1 inhibitors to halt axonal degeneration and treat diseases such as multiple sclerosis and amyotrophic lateral sclerosis.
--
United States of America
unclear
January 01, 2016
info@disarmtx.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Gene Technology Biotechnology